Skip to main content
Premium Trial:

Request an Annual Quote

Blueprint Initiative Secures Funding for Asian Node, Launches European Node

NEW YORK, Aug. 3, (GenomeWeb News) - The Blueprint Initiative has secured funding to expand its Biomolecular Interaction Network Database through launching Blueprint Asia in Singapore, and has also launched Blueprint Europe, the organization said today.


Blueprint, based in Toronto, Canada, aims to make its BIND database the largest free database of molecular assembly information from scientific journals, and the successor to GenBank. As of June this year, the database had over 80,000 molecular interactions, the organization said.


The Asian node is slated to contribute 60,000 molecular interaction networks into the BIND database. An additional 4 curators will enter these interactions into the database over the next five years, according to Blueprint Initiative Principal Investigator Dr. Christopher Hogue.


This new initiative is being supported by Singapore's economic development board, the Genomics Institute of Singapore and the National University of Singapore, along with global industry partner Sun Microsystems. Blueprint did not say how much funding would be provided by these organizations.


Blueprint Europe, which will be based in London while pursuing funding opportunities, partner with the Nature Publishing group to curate all biomolecular interactions in every Nature publication ever produced, the organization said.


The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.